» Articles » PMID: 18226221

Phosphatidylinositol 3-kinase Signaling in Proliferating Cells Maintains an Anti-apoptotic Transcriptional Program Mediated by Inhibition of FOXO and Non-canonical Activation of NFkappaB Transcription Factors

Overview
Journal BMC Cell Biol
Publisher Biomed Central
Specialty Cell Biology
Date 2008 Jan 30
PMID 18226221
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Phosphatidylinositol (PI) 3-kinase is activated by a variety of growth factor receptors and the PI 3-kinase/Akt signaling pathway is a key regulator of cell proliferation and survival. The downstream targets of PI 3-kinase/Akt signaling include direct regulators of cell cycle progression and apoptosis as well as a number of transcription factors. Growth factor stimulation of quiescent cells leads to robust activation of PI 3-kinase, induction of immediate-early genes, and re-entry into the cell cycle. A lower level of PI 3-kinase signaling is also required for the proliferation and survival of cells maintained in the presence of growth factors, but the gene expression program controlled by PI 3-kinase signaling in proliferating cells has not been elucidated.

Results: We used microarray analyses to characterize the changes in gene expression resulting from inhibition of PI 3-kinase in proliferating cells. The genes regulated by inhibition of PI 3-kinase in proliferating cells were distinct from genes induced by growth factor stimulation of quiescent cells and highly enriched in genes that regulate programmed cell death. Computational analyses followed by chromatin immunoprecipitations demonstrated FOXO binding to both previously known and novel sites in promoter regions of approximately one-third of the up-regulated genes, consistent with activation of FOXO1 and FOXO3a in response to inhibition of PI 3-kinase. NFkappaB binding sites were similarly identified in promoter regions of over one-third of the down-regulated genes. RelB was constitutively bound to promoter regions in cells maintained in serum, however binding decreased following PI 3-kinase inhibition, indicating that PI 3-kinase signaling activates NFkappaB via the non-canonical pathway in proliferating cells. Approximately 70% of the genes targeted by FOXO and NFkappaB regulate cell proliferation and apoptosis, including several regulators of apoptosis that were not previously known to be targeted by these transcription factors.

Conclusion: PI 3-kinase signaling in proliferating cells regulates a novel transcriptional program that is highly enriched in genes that regulate apoptosis. At least one-third of these genes are regulated either by FOXO transcription factors, which are activated following PI 3-kinase inhibition, or by RelB, which is activated by PI 3-kinase via the non-canonical pathway in proliferating cells.

Citing Articles

Caloric restriction inhibits renal artery ageing by reducing endothelin-1 expression.

Wang X, Ao Q, Cheng Q Ann Transl Med. 2021; 9(12):979.

PMID: 34277779 PMC: 8267285. DOI: 10.21037/atm-21-2218.


Protein synthesis inhibitors stimulate MondoA transcriptional activity by driving an accumulation of glucose 6-phosphate.

Wilde B, Kaadige M, Guillen K, Butterfield A, Welm B, Ayer D Cancer Metab. 2020; 8(1):27.

PMID: 33292639 PMC: 7718662. DOI: 10.1186/s40170-020-00233-6.


L-Carnitine Attenuates Cardiac Dysfunction by Ischemic Insults Through Akt Signaling Pathway.

Xue M, Chen X, Guo Z, Liu X, Bi Y, Yin J Toxicol Sci. 2017; 160(2):341-350.

PMID: 28973678 PMC: 5837463. DOI: 10.1093/toxsci/kfx193.


Transcriptomic analysis identifies a role of PI3K-Akt signalling in the responses of skeletal muscle to acute hypoxia in vivo.

Gan Z, Powell F, Zambon A, Buchholz K, Fu Z, Ocorr K J Physiol. 2017; 595(17):5797-5813.

PMID: 28688178 PMC: 5577531. DOI: 10.1113/JP274556.


β-Caryophyllene Pretreatment Alleviates Focal Cerebral Ischemia-Reperfusion Injury by Activating PI3K/Akt Signaling Pathway.

Zhang Q, An R, Tian X, Yang M, Li M, Lou J Neurochem Res. 2017; 42(5):1459-1469.

PMID: 28236211 DOI: 10.1007/s11064-017-2202-3.


References
1.
Bakker W, Blazquez-Domingo M, Kolbus A, Besooyen J, Steinlein P, Beug H . FoxO3a regulates erythroid differentiation and induces BTG1, an activator of protein arginine methyl transferase 1. J Cell Biol. 2004; 164(2):175-84. PMC: 2172323. DOI: 10.1083/jcb.200307056. View

2.
van der Horst A, Burgering B . Stressing the role of FoxO proteins in lifespan and disease. Nat Rev Mol Cell Biol. 2007; 8(6):440-50. DOI: 10.1038/nrm2190. View

3.
Sandri M, Sandri C, Gilbert A, Skurk C, Calabria E, Picard A . Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell. 2004; 117(3):399-412. PMC: 3619734. DOI: 10.1016/s0092-8674(04)00400-3. View

4.
Yang H, Sadda M, Yu V, Zeng Y, Lee T, Ou X . Induction of human methionine adenosyltransferase 2A expression by tumor necrosis factor alpha. Role of NF-kappa B and AP-1. J Biol Chem. 2003; 278(51):50887-96. DOI: 10.1074/jbc.M307600200. View

5.
Takahashi Y, Rayman J, Dynlacht B . Analysis of promoter binding by the E2F and pRB families in vivo: distinct E2F proteins mediate activation and repression. Genes Dev. 2000; 14(7):804-16. PMC: 316494. View